by James Templeton | Mar 8, 2026 | Articles
How did a $7 dog dewormer ignite a global conversation about cancer treatment—and what does the Joe Tippens story reveal about fenbendazole, ivermectin, and the science behind these repurposed compounds?
by James Templeton | Mar 6, 2026 | News
The bright red color of cherries comes from powerful plant compounds—and new research suggests they may influence cancer cells in surprising ways.
by James Templeton | Feb 26, 2026 | Articles
What would lead cancer patients to travel across the border in search of a treatment they couldn’t receive at home? You might be surprised.
by James Templeton | Feb 24, 2026 | News
According to medical data, thyroid and prostate cancers now show five-year survival rates approaching 97% to 99%, with similarly high outcomes for testicular cancer, melanoma, and early-stage breast cancer. Here’s why.
by Ben Clark | Feb 11, 2026 | Expert Interviews
James Templeton sits down with John A. Richardson, Jr. to explore one of the most debated chapters in integrative cancer history: amygdalin — also known as vitamin B-17 or laetrile.